Understand what AMH levels mean for ovarian reserve, why they cannot predict natural conception, and how to discuss low or high results with a clinician.

In short
From Vively member data
An AMH level helps assess ovarian reserve and likely response to ovarian stimulation, but it cannot tell you whether you will conceive naturally. It is not a direct egg count or a measure of egg quality. Your clinician interprets the result alongside age, symptoms, medical history and the reason for testing.
| Question | Useful interpretation | Limit |
|---|---|---|
| How might the ovaries respond to stimulation? | AMH can help estimate ovarian response in fertility treatment | It does not guarantee eggs retrieved or a successful pregnancy. |
| Can I conceive naturally? | A fertility assessment may consider many factors | AMH alone does not answer this question. |
| Does a high result mean PCOS? | It may contribute to assessment in appropriate adult patients | It is not a standalone diagnosis. |
| When will menopause happen? | A clinician considers symptoms and history | AMH cannot give a reliable personal countdown. |
If you searched for normal AMH levels, start with the actual report rather than an online chart. The laboratory method and units matter. A result labelled low or high deserves an explanation of what it means for the question your clinician is trying to answer, not an immediate verdict about your reproductive future.
AMH is produced by cells around small developing follicles in the ovaries. Its blood concentration can provide information about the pool of follicles that may respond to stimulation. That is why fertility specialists use it when planning some treatments. It does not literally count every egg remaining in the ovaries.
Ovarian reserve concerns quantity, while egg quality and the chance of pregnancy involve other factors. AMH cannot assess every stage needed for conception, including ovulation, sperm factors and fallopian tube function. A reassuring-looking result should not delay an assessment when you have symptoms or difficulty conceiving.
The American Society for Reproductive Medicine distinguishes useful prediction of ovarian response from prediction of pregnancy outcomes. That distinction can reduce unnecessary alarm after a result. You can have a meaningful conversation about treatment planning without treating the laboratory value as a complete fertility score.
There is no universal AMH number that separates fertile from infertile. Australian results should be interpreted using the laboratory’s own method, units and reference information, together with your clinical circumstances. A chart copied from another country may use different units or thresholds designed for a different purpose.
Pathology Tests Explained notes substantial variation between laboratories and advises familiarity with the method and reference interval being used. If you compare results over time, bring the original reports rather than just the numbers. Your clinician can check whether a change in laboratory or method affects the comparison.
Age-based reference charts describe patterns in groups; they do not give your personal chance of pregnancy. Ask your clinician what the result changes in your care, whether another assessment is needed and whether repeating the test would add useful information.
A low AMH result can suggest lower ovarian reserve in the relevant clinical setting. It may help a specialist anticipate a lower response to ovarian stimulation. It does not establish that natural conception is impossible, and it should not be used alone to decide that fertility treatment cannot be worthwhile.
Interpretation depends on the reason for testing. Someone preparing for ovarian stimulation is asking a different question from someone without symptoms who has bought a screening panel. Age, treatment history and other findings matter. Your clinician should explain the limits before the result is used to make a major personal decision.
If the result is unexpected, avoid immediately ordering supplements or repeated tests from different providers. Ask whether medication, hormonal contraception or the testing method could affect interpretation. Do not stop contraception or other prescribed care on your own to change a blood result. Agree on any next step with your treating clinician.
A high AMH result may be associated with a larger pool of small follicles or with the condition commonly known as PCOS. Current Monash guidance also uses the name polyendocrine metabolic ovarian syndrome, or PMOS. The guideline says AMH should not be used as a single test to make that diagnosis. AMH is not recommended for diagnosing this condition in adolescents.
A specialist assesses the broader pattern, including menstrual history and other appropriate findings. A high result does not guarantee regular ovulation, better egg quality or easy conception. Our hormone results guide explains why a single marker needs context.
If you already have a PCOS diagnosis, discuss fertility and metabolic questions with your treating team rather than trying to lower AMH as an isolated goal. Our PCOS food and nutrition article covers a separate part of care.
AMH is often used in planning ovarian stimulation for IVF or egg freezing. It can contribute to estimates of response and help a specialist discuss treatment expectations. It cannot guarantee how many eggs will be collected, whether an embryo will develop or whether a live birth will occur.
Testing as a general screen for future fertility is a different use. ASRM guidance cautions against using ovarian reserve markers as a fertility test in people with untested fertility. A result can cause anxiety without answering when you should try for pregnancy. Discuss your goals and circumstances before deciding to test.
AMH also cannot provide a reliable personal date for menopause. If periods have changed or stopped, assessment should consider symptoms and other clinical information. Our perimenopause testing guide explains why a history may matter more than a broad panel. Do not use a low value as a substitute for that assessment.
Your clinician or pathology provider should give preparation instructions for the actual request. AMH can often be measured without choosing a particular cycle day, but other tests ordered alongside it may have timing or fasting requirements. Follow the instructions for the complete request rather than assuming every fertility panel is the same.
Tell the clinician about hormonal contraception, medicines, supplements and relevant treatment history. Ask whether they affect interpretation or the timing of testing. Bring prior results if available. You do not need to change your diet or take products claiming to improve egg reserve before the appointment.
A written period and symptom record can be useful even when no app is needed. Our period tracker comparison explains privacy and prediction limits. The record is there to help describe your experience, not to replace a clinical assessment.
A fertility assessment is tailored to the people and circumstances involved. It may include menstrual and ovulation history, pelvic ultrasound, other hormone tests or assessment of fallopian tubes. Where relevant, a partner’s semen analysis may be part of the picture. Not everyone needs every possible test.
Ask which test answers which question. Repeating a marker because it feels reassuring may be less useful than investigating a symptom the marker cannot explain. The goal is a plan you understand, including what can be learned now and what remains uncertain. Your GP can discuss referral to a fertility specialist when appropriate.
Supplements sold for hormone balance or egg quality should not be assumed to raise meaningful fertility outcomes. Our hormone supplement evidence guide explains why a plausible mechanism is not proof of a treatment effect. Avoid making a laboratory number the sole target of care.
Vively’s Baseline Health Check does not replace a fertility assessment. Check AMH availability in the test directory and ask your treating clinician which tests would inform your care. The Baseline Health Check includes 70+ markers and a practitioner consultation to explain your results. Read how membership works for the details.
The Baseline Health Check is included in Vively membership, with a practitioner consultation to explain results and a personal testing plan.
No. A low result can suggest reduced ovarian reserve, but it does not establish that natural conception is impossible. AMH is more useful for discussing likely response to ovarian stimulation than predicting an individual pregnancy. Your clinician should interpret it alongside age, history and other relevant fertility factors.
No. AMH should not be used alone to diagnose PCOS. A clinician considers the wider clinical pattern and appropriate diagnostic criteria. High AMH also does not guarantee easy conception or establish egg quality. Ask what other information is needed for your circumstances.
Do not assume a supplement can restore ovarian reserve or improve pregnancy outcomes because it changes a laboratory marker. Products and outcomes need their own evidence. Discuss any deficiency or proposed supplement with your treating clinician, and avoid replacing fertility assessment with an attempt to raise AMH in isolation.
Use caution. Laboratory methods, units and clinical purposes differ, and an age chart is not a fertility prediction. Take the full report to your clinician and ask how the value informs your care. A comparison can look alarming or reassuring without showing your chance of natural conception or the timing of menopause.
The Baseline Health Check is a blood test covering 70+ markers at one of 3,700+ collection centres. Your dietitian goes through your results with you and builds your plan. $99$79 this Black Friday, ends 1 Dec. Then $99 a month, cancel anytime.